Bristol-Myers confirms activist Starboard has its shares. And it wants board seats, too

When it comes to Bristol-Myers Squibb, the rumors are true. Activist investor Starboard Value has indeed taken a stake in the merger-bound pharma—and it’s looking to meddle further.